Midatech Pharma Competitors and Similar CompaniesClear all

F-star Biotechnology's competitors and similar companies include Quark Pharmaceuticals and KemPharm.
F-star Biotechnology
F-star Biotechnology
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
Quark Pharmaceuticals
Quark Pharmaceuticals
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
KemPharm
KemPharm
KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.
Founding Date
Founding Date
2006
Founding Date
1994
Founding Date
2006
Type
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, GB HQ
Wien, AT
Cambridge, US
Locations
Newark, US HQ
Locations
Kissimmee, US HQ
Blacksburg, US
Coralville, US
Coralville, US
Employees
Employees
39
Employees
781% decrease
Employees
333% increase

Financial

Revenue (est.)
Revenue (est.)
£18.7m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$106.5m (FY, 2025)
Net income
Net income
(£2.6m) (FY, 2018)
Net income
N/A
Net income
$83.2m (FY, 2025)

Funding

Latest funding round
Latest funding round
$ 9.4m (over 12 years ago)
Latest funding round
$ 10m (almost 16 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 57.3m
Total funding raised
$ 37m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Quark Pharmaceuticals
HQ
Newark, US
Employees
78↓ 1% decrease

Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.

View company
KemPharm
HQ
Kissimmee, US
Employees
33↑ 3% increase

KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases.

View company